What Pharma Can Learn from Patients: A Global Patient Advocate Survey
In June we asked Pharma what one question they’d ask patient advocates about trial participation. Through partnering with MK&A eyeforpharma has been able to send the questions to patient advocates across the globe. Now we have the results. Scroll down to read the findings with in depth analysis from Merck, the FDA and Horizon Pharma.

The whitepaper was conducted through research for Patient Centered Clinical Trials, the 3rd annual summit focused on harnessing the power of patients.

Enter your details on the right to find out more.>>
eyeforpharma Ltd, headquartered at 7-9 Fashion Street, London, E1 6PX, United Kingdom. A registered company in England and Wales: 09823909. | Terms and conditions
Katie Gadsby
Global Project Director
eyeforpharma
E- kgadsby@eyeforpharma.com
T- + 44 (0) 207 375 7591
If you are interested in the topics of this whitepaper you may also be interested in Patient Centered Clinical Trials.

To hear more from the contributors of this paper enter your details on the right >>

Best wishes,

Katie

Content unavailable.

Download your brochure